Log in to search using one of your social media accounts:

 

Environmental Triggers of COPD Symptoms Environmental Triggers of COPD Symptoms
Learn which common environmental exposures may trigger COPD exacerbations.BMJ Open Respiratory Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 25, 2017 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

Hidden Respiratory Dangers at Home
Household bleach may not lead to COPD, as recently reported in the lay press, but a number of respiratory dangers are present in many US homes. (Source: ConsultantLive)
Source: ConsultantLive - September 21, 2017 Category: Internal Medicine Authors: Jonathan Ilowite, MD Tags: Respiratory Diseases Source Type: news

Steroid inhalers linked to higher risk of hard-to-treat infections
Older people who use steroid inhalers for asthma or chronic obstructive pulmonary disease are more likely to experience particular bacterial infections, according to a large Canadian study. (Source: Nursing Times)
Source: Nursing Times - September 21, 2017 Category: Nursing Source Type: news

Following regulatory win, GSK & Innoviva tout data for once-daily triple-med inhaler
GlaxoSmithKline (NYSE:GSK) and Innoviva (NSDQ:INVA) notched a win this week after the FDA approved its once-daily, triple combination therapy for the treatment of chronic obstructive pulmonary disease. Last week, an EU agency recommended the inhaler’s approval. Now, the companies are touting results from a late-stage trial of Trelegy Ellipta, which is composed of an inhaled corticosteroid, a long-acting muscarinic antagonist and a long-acting beta agonist. Get the full story at our sister site, Drug Delivery Business News. The post Following regulatory win, GSK & Innoviva tout data f...
Source: Mass Device - September 20, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat GlaxoSmithKline plc Innoviva Source Type: news

Medicine in the Headlines: When Your Patients Ask
HRT, tattoos, insurers exacerbating the opioid epidemic, prolonged sitting, plus a new COPD drug: here's a recap of 5 of the week's key news reports. (Source: ConsultantLive)
Source: ConsultantLive - September 20, 2017 Category: Internal Medicine Authors: Susan Kweskin Tags: Addiction COPD Source Type: news

GSK's new triple lung drug beats other modern inhalers in study
LONDON (Reuters) - GlaxoSmithKline produced clinical data on Wednesday showing its newly approved three-in-one inhaler reduced life-threatening attacks in chronic obstructive pulmonary disease (COPD) patients more than other modern treatments. (Source: Reuters: Health)
Source: Reuters: Health - September 20, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

COPD (Chronic Obstructive Pulmonary Disease) Quiz
Title: COPD (Chronic Obstructive Pulmonary Disease) QuizCategory: MedicineNet QuizCreated: 10/8/2012 5:18:00 PMLast Editorial Review: 9/20/2017 12:59:09 PM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - September 20, 2017 Category: Respiratory Medicine Source Type: news

Breathing-Swallowing Discoordination and COPD Exacerbations Breathing-Swallowing Discoordination and COPD Exacerbations
COPD patients with impaired coordination between breathing and swallowing may be more likely to experience frequent exacerbations.BMJ Open Respiratory Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 20, 2017 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

Treating asthma or COPD with steroid inhaler raises the risk of hard-to-treat infections
(European Lung Foundation) Older people who use steroid inhalers for asthma or COPD are more likely to suffer particular bacterial infections, according to a large study published in the European Respiratory Journal. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 20, 2017 Category: Infectious Diseases Source Type: news

FDA Approves Trelegy Ellipta for COPD FDA Approves Trelegy Ellipta for COPD
The FDA has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta, GlaxoSmithKline) for patients with COPD.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 19, 2017 Category: Consumer Health News Tags: Pulmonary Medicine News Alert Source Type: news

Implementing MTM for COPD Implementing MTM for COPD
Medication therapy management plays an important role in helping patients learn how to manage COPD and decrease complications. Learn about MTM interventions for COPD in this primer.U.S. Pharmacist (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 19, 2017 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

FDA approves GSK ’ s 3-in-1 Trelega Ellipta inhaler
The FDA has approved the triple inhaler developed by GlaxoSmithKline (NYSE:GSK) and Innoviva (NSDQ:INVA) to treat chronic obstructive pulmonary disease, the companies reported today. The Trelega Ellipta dry powder inhaler uses fluticasone furoate, umeclidinium and vilanterol to help adults with COPD manage the condition. It is the first once-daily product approved in the U.S. that combines three active molecules in a single inhaler for COPD patients. Get the full story at our sister site, Drug Delivery Business News. The post FDA approves GSK’s 3-in-1 Trelega Ellipta inhaler appeared first on Mass...
Source: Mass Device - September 19, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Respiratory Wall Street Beat GlaxoSmithKline plc Innoviva Source Type: news

Conventional household cleaners can kill you with increased risk of fatal lung disease
(Natural News) Chronic obstructive pulmonary disease (COPD) is a life-threatening condition that results in obstructed airflow and difficulty breathing. There are two main illnesses associated with COPD: Chronic bronchitis, which affects more than 10 million Americans, and emphysema, which over 4.7 million Americans have been diagnosed with. While the most common cause of COPD is... (Source: NaturalNews.com)
Source: NaturalNews.com - September 19, 2017 Category: Consumer Health News Source Type: news

U.S. FDA approves GSK's three-in-one drug inhaler for COPD
(Reuters) - GlaxoSmithKline Plc and Innoviva Inc said on Monday the U.S. Food and Drug Administration has approved their triple drug inhaler for treatment of chronic obstructive pulmonary disease (COPD). (Source: Reuters: Health)
Source: Reuters: Health - September 18, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of COPD
London UK – 18 September 2017 -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple therapy fluticasone... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 18, 2017 Category: Drugs & Pharmacology Source Type: news

Is it Common to Have Pneumothorax with COPD?
Title: Is it Common to Have Pneumothorax with COPD?Category: Doctor's& Expert's views on SymptomsCreated: 9/18/2017 12:00:00 AMLast Editorial Review: 9/18/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - September 18, 2017 Category: Respiratory Medicine Source Type: news

CHMP Backs Two New Inhalers Inhalers for COPD CHMP Backs Two New Inhalers Inhalers for COPD
Elebrato Ellipta and Trelegy Ellipta contain the triple combination of fluticasone furoate, umeclidinium, and vilanterol and are for inadequately controlled moderate to severe COPD in adults.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 15, 2017 Category: Consumer Health News Tags: Pulmonary Medicine News Alert Source Type: news

EMA Panel Backs Two New Inhalers for COPD EMA Panel Backs Two New Inhalers for COPD
Elebrato Ellipta and Trelegy Ellipta contain the triple combination of fluticasone furoate, umeclidinium, and vilanterol and are for inadequately controlled moderate to severe COPD in adults.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 15, 2017 Category: Consumer Health News Tags: Pulmonary Medicine News Alert Source Type: news

GSK ’s triple-med COPD inhaler wins recommendation for approval in EU
GlaxoSmithKline (NYSE:GSK) and Innoviva (NSDQ:INVA) said today that a European Medicines Agency panel recommended marketing authorization for the Trelegy Ellipta triple-combination inhaler for adults with COPD. The device uses fluticasone furoate, umeclidinium and vilanterol to help adults with COPD who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist. It’s also the first once-daily single inhaler triple therapy to win a positive opinion by the Committee for Medicinal Products for Human Use, the companies reported. Get the full story at our sister...
Source: Mass Device - September 15, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pharmaceuticals Regulatory/Compliance Respiratory Wall Street Beat GlaxoSmithKline plc Innoviva Source Type: news

GSK reports positive Phase III results of mepolizumab for COPD
GlaxoSmithKline (GSK) has reported positive results from two Phase III clinical trials of mepolizumab to treat patients with eosinophilic chronic obstructive pulmonary disease (COPD). (Source: Drug Development Technology)
Source: Drug Development Technology - September 13, 2017 Category: Pharmaceuticals Source Type: news

ERS: Eosinophilia May Up Risk for COPD Readmission (CME/CE)
(MedPage Today) -- Also, IL-8 and MUC2 tied to exacerbations (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - September 13, 2017 Category: General Medicine Source Type: news

Regular Use of Bleach Linked to COPD
Study finds risk of lung disease from prolonged exposure to some disinfectants. (Source: WebMD Health)
Source: WebMD Health - September 13, 2017 Category: Consumer Health News Source Type: news

Mepolizumab Showing Promise for High-Risk Eosophilic COPD Mepolizumab Showing Promise for High-Risk Eosophilic COPD
A biologic that targets interleukin-5 could reduce COPD exacerbations in patients with high blood eosinophil counts, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 13, 2017 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

Mepolizumab Showing Promise for High-Risk Eosinophilic COPD Mepolizumab Showing Promise for High-Risk Eosinophilic COPD
A biologic that targets interleukin-5 could reduce COPD exacerbations in patients with high blood eosinophil counts, new research shows.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 13, 2017 Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news

Regular Use of Bleach Linked to COPD
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - September 13, 2017 Category: General Medicine Source Type: news

Regular Use of Bleach Linked to COPD
Title: Regular Use of Bleach Linked to COPDCategory: Health NewsCreated: 9/13/2017 12:00:00 AMLast Editorial Review: 9/13/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - September 13, 2017 Category: Respiratory Medicine Source Type: news

Mepolizumab Beneficial in COPD With Eosinophilic Phenotype
Lower annual rate of moderate, severe exacerbations for patients receiving 100 mg mepolizumab (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 12, 2017 Category: Respiratory Medicine Tags: Internal Medicine, Allergy, Pharmacy, Pulmonology, Geriatrics, Conference News, Source Type: news

Exposure to Disinfectants Linked to COPD Exposure to Disinfectants Linked to COPD
There is an association between the regular use of cleaning products and the development of COPD, an analysis of data from the Nurses'Health Study II shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 12, 2017 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

ERS: Mixed Results for Biologic in Eosinophilic COPD (CME/CE)
(MedPage Today) -- May work better for patients with higher blood eosinophil counts (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - September 12, 2017 Category: Allergy & Immunology Source Type: news

Therapy proves effective in subgroup of COPD patients
(University of Pittsburgh Schools of the Health Sciences) Antibody treatment reduces rate of flare-ups in patients with a subgroup of treatment-resistant COPD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 12, 2017 Category: International Medicine & Public Health Source Type: news

Regular use of disinfectants by nurses 'increases COPD risk'
Regular use of disinfectants is linked to a higher risk of developing chronic obstructive pulmonary disease (COPD) among nurses, according to a large study looking at thousands of clinicians. (Source: Nursing Times)
Source: Nursing Times - September 12, 2017 Category: Nursing Source Type: news

Antibody therapy reduces flare-ups in treatment-resistant COPD
Results come from two trials presented at European Respiratory Society International Congress Related items fromOnMedica Making sense of the new LABAs and LAMAs for COPD Physical activity decreases risk of dying in COPD End-of-life care in COPD Diagnosis of COPD needs to be improved CVD event risk raised soon after COPD exacerbations (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 12, 2017 Category: UK Health Source Type: news

ERS: Disinfectant Use Tied to COPD Incidence in Nurses (CME/CE)
(MedPage Today) --'Novel hypothesis merits further investigation,'researchers say (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - September 11, 2017 Category: Consumer Health News Source Type: news

COPD With Hypercapnia: Effects of NIV on Readmission COPD With Hypercapnia: Effects of NIV on Readmission
Dr Shorr discusses acute exacerbation of COPD, reviewing findings from a randomized controlled trial on the effects of noninvasive ventilation with supplemental oxygen for these patients.Medscape Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 11, 2017 Category: Consumer Health News Tags: Pulmonary Medicine Commentary Source Type: news

Medical News Today: Household bleach may raise chronic lung disease risk
A new study finds a strong correlation between regular use of disinfectants such as bleach and an increased risk of chronic obstructive pulmonary disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 11, 2017 Category: Consumer Health News Tags: COPD Source Type: news

Lung disease warning: This common household product could be linked to COPD risk
COPD - Chronic Obstructive Pulmonary Disease – is a common form of lung disease that includes emphysema and chronic bronchitis. (Source: Daily Express - Health)
Source: Daily Express - Health - September 11, 2017 Category: Consumer Health News Source Type: news

Inserm study says common cleaning products can cause COPD
Regularly breathing in the strong cleaning chemicals can increase the risk of developing chronic obstructive pulmonary disease (COPD) – usually associated with smoking – by up to 32 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - September 11, 2017 Category: Consumer Health News Source Type: news

Using household cleaning products can cause lung disease
Regularly breathing in the strong cleaning chemicals can increase the risk of developing chronic obstructive pulmonary disease (COPD) – usually associated with smoking – by up to 32 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - September 11, 2017 Category: Consumer Health News Source Type: news

Nurses' regular use of disinfectants is associated with developing COPD
(European Lung Foundation) Regular use of disinfectants is linked to a higher risk of developing chronic obstructive pulmonary disease (COPD), according to new research looking at incidence of the disease in over 55,000 nurses in the USA, to be presented at the European Respiratory Society International Congress. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 10, 2017 Category: International Medicine & Public Health Source Type: news

PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include a new antibody for asthma, early treatment in COPD, mumps vaccine to curtail an outbreak, and medical exemptions from routine vaccinations (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - September 9, 2017 Category: Geriatrics Source Type: news

Airway Mucin Concentrations May Help Predict Chronic Bronchitis
Mean total mucin concentrations up in smokers with severe COPD, those with respiratory exacerbations (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 8, 2017 Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Infections, Internal Medicine, Pathology, Pulmonology, Journal, Source Type: news

Statins Tied to Reduced Mortality Risk in COPD
Statin exposure associated with lower all - cause, pulmonary mortality (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 8, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Geriatrics, Internal Medicine, Nursing, Pharmacy, Pulmonology, Journal, Source Type: news

Statins May Help People With COPD Live Longer
Deaths from lung-related causes were reduced by as much as 45 percent, study suggests (Source: WebMD Health)
Source: WebMD Health - September 8, 2017 Category: Consumer Health News Source Type: news

Statins May Help People With COPD Live Longer
Deaths from lung - related causes were reduced by as much as 45 percent, study suggests (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 8, 2017 Category: Respiratory Medicine Tags: Pharmacy, Pulmonology, News, Source Type: news

Statins May Help People with COPD Live Longer
Deaths from lung-related causes were reduced by as much as 45 percent, study suggests Source: HealthDay Related MedlinePlus Pages: COPD, Statins (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 8, 2017 Category: Consumer Health News Source Type: news

Statins May Help People With COPD Live Longer
FRIDAY, Sept. 8, 2017 -- Drugs known as statins may have benefits beyond lowering " bad " LDL cholesterol levels. A new study suggests people with chronic lung disease who take these drugs may extend their survival. The study from Canada included... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 8, 2017 Category: General Medicine Source Type: news

Statins May Help People With COPD Live Longer
Title: Statins May Help People With COPD Live LongerCategory: Health NewsCreated: 9/8/2017 12:00:00 AMLast Editorial Review: 9/8/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - September 8, 2017 Category: Respiratory Medicine Source Type: news

Tiotropium Effective in Mild to Moderate COPD
Daily inhaled dose tied to improvements in FEV1 compared to placebo (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 7, 2017 Category: Respiratory Medicine Tags: Internal Medicine, Pharmacy, Pulmonology, Journal, Source Type: news

Long-acting inhaler may help in early stage COPD
The inhaler medication Spiriva may help slow the progression of COPD if given in the early stages of the disease, a new study suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 7, 2017 Category: Consumer Health News Source Type: news

Long-Acting Inhaler May Help in Early Stage COPD, Too
Title: Long-Acting Inhaler May Help in Early Stage COPD, TooCategory: Health NewsCreated: 9/6/2017 12:00:00 AMLast Editorial Review: 9/7/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - September 7, 2017 Category: Respiratory Medicine Source Type: news